Indivior hit hard as generic Suboxone defence crumblesIndivior has suffered a critical defeat in the US courts for opioid addiction product Suboxone Film, opening the Share XIndivior hit hard as generic Suboxone defence crumbleshttps://pharmaphorum.com/news/indivior-hit-hard-as-generic-suboxone-defence-crumbles/
Indivior’s once-monthly schizophrenia injection gets US green lightRegulators authorities in the US have approved Indivior’s long-acting injectable treatment for adults with schizophrenia. Perseris (risperidone) won Share XIndivior’s once-monthly schizophrenia injection gets US green lighthttps://pharmaphorum.com/news/indivior-schizophrenia-perseris-fda/
